Clovis Oncology, Inc.
Clovis Oncology, Inc. (C6O.DE) Stock Overview
Explore Clovis Oncology, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.2M
P/E Ratio
-0.05
EPS (TTM)
$-1.98
ROE
1.21%
C6O.DE Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Clovis Oncology, Inc. (C6O.DE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.05.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.05 and a market capitalization of 13.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.